Rankings
▼
Calendar
JBIO FY 2020 Earnings — Jade Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
JBIO
Jade Biosciences, Inc.
$491M
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$1,000
Operating Income
-$9M
Net Income
-$10M
EPS (Diluted)
$-14.00
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$8M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$5M
Total Liabilities
$2M
Stockholders' Equity
$3M
Cash & Equivalents
$5M
← FY 2021
All Quarters